Variants in the HEPSIN Gene Are Associated with Prostate Cancer in Men of European Origin

Overview

Journal Hum Genet

Specialty Genetics

Date 2006 Jun 20

PMID 16783571

Citations 14

Authors

Prodipto Pal

Huifeng Xi

Ritesh Kaushal

Guangyun Sun

Carol H Jin

Li Jin

Brian K Suarez

William J Catalona

Ranjan Deka

Affiliations

Soon will be listed here.

Abstract

There is considerable evidence that genetic factors are involved in prostate cancer susceptibility. We have studied the association of 11 single nucleotide polymorphisms (SNPs) in the HEPSIN gene (HPN) with prostate cancer in men of European ancestry. HPN is a likely candidate in prostate cancer susceptibility, as it encodes a transmembrane cell surface serum protease, which is overexpressed in prostate cancer; HPN is also located on 19q11-q13.2, where linkage is found with prostate cancer susceptibility. In this case-control association study (590 men with histologically verified prostate cancer and 576 unrelated controls, all of European descent), we find significant allele frequency differences between cases and controls at five SNPs that are located contiguously within the gene. A major 11-locus haplotype is significantly associated, which provides further support that HPN is a potentially important candidate gene involved in prostate cancer susceptibility. Association of one of the SNPs with Gleason score is also suggestive of a plausible role of HPN in tumor aggressiveness.

Citing Articles

Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.

Lu L, Cole A, Huang D, Wang Q, Guo Z, Yang W Biomolecules. 2022; 12(2).

PMID: 35204704 PMC: 8961580. DOI: 10.3390/biom12020203.

Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.

Mukai S, Yamasaki K, Fujii M, Nagai T, Terada N, Kataoka H Int J Mol Sci. 2020; 21(8).

PMID: 32290402 PMC: 7215454. DOI: 10.3390/ijms21082663.

Cell surface-anchored serine proteases in cancer progression and metastasis.

Martin C, List K Cancer Metastasis Rev. 2019; 38(3):357-387.

PMID: 31529338 PMC: 6893142. DOI: 10.1007/s10555-019-09811-7.

The role of type II transmembrane serine protease-mediated signaling in cancer.

Tanabe L, List K FEBS J. 2016; 284(10):1421-1436.

PMID: 27870503 PMC: 5432387. DOI: 10.1111/febs.13971.

Type II transmembrane serine protease gene variants associate with breast cancer.

Luostari K, Hartikainen J, Tengstrom M, Palvimo J, Kataja V, Mannermaa A PLoS One. 2014; 9(7):e102519.

PMID: 25029565 PMC: 4100901. DOI: 10.1371/journal.pone.0102519.

References

Suarez B, Pal P, Jin C, Kaushal R, Sun G, Jin L . TGFBR1*6A is not associated with prostate cancer in men of European ancestry. Prostate Cancer Prostatic Dis. 2004; 8(1):50-3. DOI: 10.1038/sj.pcan.4500765. View

Xu J, Stolk J, Zhang X, Silva S, Houghton R, Matsumura M . Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000; 60(6):1677-82. View

Smith D, Humphrey P, Catalona W . The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer. 1997; 80(9):1852-6. View

Witte J, Suarez B, Thiel B, Lin J, Yu A, Banerjee T . Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate. 2003; 57(4):298-308. DOI: 10.1002/pros.10304. View

Rhodes D, Barrette T, Rubin M, Ghosh D, Chinnaiyan A . Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 2002; 62(15):4427-33. View

Witte J, Goddard K, Conti D, Elston R, Lin J, Suarez B . Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet. 2000; 67(1):92-9. PMC: 1287106. DOI: 10.1086/302960. View

Simard J, Dumont M, Soucy P, Labrie F . Perspective: prostate cancer susceptibility genes. Endocrinology. 2002; 143(6):2029-40. DOI: 10.1210/endo.143.6.8890. View

Suarez B, Lin J, Witte J, Conti D, Resnick M, Klein E . Replication linkage study for prostate cancer susceptibility genes. Prostate. 2000; 45(2):106-14. DOI: 10.1002/1097-0045(20001001)45:2<106::aid-pros4>3.0.co;2-h. View

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

10.

Stephan C, Yousef G, Scorilas A, Jung K, Jung M, Kristiansen G . Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J Urol. 2003; 171(1):187-91. DOI: 10.1097/01.ju.0000101622.74236.94. View

11.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C . Cancer statistics, 2006. CA Cancer J Clin. 2006; 56(2):106-30. DOI: 10.3322/canjclin.56.2.106. View

12.

Boehnke M . Allele frequency estimation from data on relatives. Am J Hum Genet. 1991; 48(1):22-5. PMC: 1682747. View

13.

Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E . Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol. 1999; 154(1):83-95. PMC: 1853424. DOI: 10.1016/S0002-9440(10)65254-6. View

14.

Jiang Z, Zhang X, Deka R, Jin L . Genome amplification of single sperm using multiple displacement amplification. Nucleic Acids Res. 2005; 33(10):e91. PMC: 1143700. DOI: 10.1093/nar/gni089. View

15.

Goddard K, Witte J, Suarez B, Catalona W, Olson J . Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet. 2001; 68(5):1197-206. PMC: 1226100. DOI: 10.1086/320103. View

16.

Sun G, Kaushal R, Pal P, Wolujewicz M, Smelser D, Cheng H . Whole-genome amplification: relative efficiencies of the current methods. Leg Med (Tokyo). 2005; 7(5):279-86. DOI: 10.1016/j.legalmed.2005.05.001. View

17.

Suarez B, Lin J, Burmester J, Broman K, Weber J, Banerjee T . A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet. 2000; 66(3):933-44. PMC: 1288174. DOI: 10.1086/302818. View

18.

Baker S, Lichtenstein P, Kaprio J, Holm N . Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics. 2005; 61(1):55-63. DOI: 10.1111/j.0006-341X.2005.030924.x. View

19.

Chen Z, Fan Z, McNeal J, Nolley R, Caldwell M, Mahadevappa M . Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol. 2003; 169(4):1316-9. DOI: 10.1097/01.ju.0000050648.40164.0d. View

20.

Stamey T, Warrington J, Caldwell M, Chen Z, Fan Z, Mahadevappa M . Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol. 2001; 166(6):2171-7. View